Non-Alcoholic Fatty Liver Disease Trial, Recruiting (NCT05477212)

Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT05477212 Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis Condition: Non-Alcoholic Fatty Liver Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05477212 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Non Alcoholic Fatty Liver Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have a BMI of 30 or higher, OR a waist measurement greater than 94 cm (about 37 inches) for men or greater than 80 cm (about 31.5 inches) for women, with or without signs of metabolic syndrome
You are between 18 and 70 years old (any sex)
You have been diagnosed with fatty liver disease, confirmed through a special scan called a FibroScan or through other recognised scoring tests that measure liver fat and scarring (confirm with trial site)

Who may not be able to join:

You have a normal body weight or are underweight
You have another health condition that could affect how well your gut lining works or could separately cause fatty liver disease (confirm with trial site)
You are currently using any medication, device, or treatment — medical or otherwise — that could affect your gut health or how your liver processes fat
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Giovanni De Pergola, Prof, IRCCS "Saverio de Bellis"

Phone: 0804994635

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05477212

Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

Phase: Not Applicable

Status: Recruiting

Condition: Non-Alcoholic Fatty Liver Disease

Trial contact: 0804994635

More information: https://clinicaltrials.gov/study/NCT05477212

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have a BMI of 30 or higher, OR a waist measurement greater than 94 cm (about 37 inches) for men or greater than 80 cm (about 31.5 inches) for women, with or without signs of metabolic syndrome
You are between 18 and 70 years old (any sex)
You have been diagnosed with fatty liver disease, confirmed through a special scan called a FibroScan or through other recognised scoring tests that measure liver fat and scarring (confirm with trial site)

Who may not be able to join:

You have a normal body weight or are underweight
You have another health condition that could affect how well your gut lining works or could separately cause fatty liver disease (confirm with trial site)
You are currently using any medication, device, or treatment — medical or otherwise — that could affect your gut health or how your liver processes fat
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

Registry

ClinicalTrials.gov

Start date

28 April 2022

Est. completion

28 May 2024

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Gut permeability; Gut Dysbiosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov